[Lipoprotein(a): influence on cardiovascular manifestation]. (Q53614132)

16 May 2018

title

[Lipoprotein(a): influence on cardiovascular manifestation]. (English)

1 reference

16 May 2018

1 reference

K-P Mellwig

1

1 reference

16 May 2018

C Schatton

2

1 reference

16 May 2018

B Biermann

3

1 reference

16 May 2018

T Kottmann

4

1 reference

16 May 2018

D Horstkotte

5

1 reference

16 May 2018

F van Buuren

6

1 reference

16 May 2018

publication date

1 April 2015

1 reference

16 May 2018

Clinical research in cardiology supplements

published in

1 reference

16 May 2018

volume

10

1 reference

16 May 2018

page(s)

33-38

1 reference

16 May 2018

Creative Commons Attribution 4.0 International

copyright license

start time

10 February 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Lipoprotein (a) Levels in Relation to Severity of Coronary Artery Disease in North Indian Patients

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Lipoprotein (a) downregulates lysosomal acid lipase and induces interleukin-6 in human blood monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Lp(a) in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Prevalence of risk factors in men with premature coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Familial lipoprotein disorders in patients with premature coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Is lipoprotein(a) a predictor for survival in patients with established coronary artery disease? Results from a prospective patient cohort study in northern Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

The significance of high levels of lipoprotein (a) compared with established risk factors in premature coronary artery disease: differences between men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Genetically elevated lipoprotein(a) and increased risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Lipoprotein(a) as a cardiovascular risk factor: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Lipoprotein(a) is associated with coronary heart disease independent of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Premature coronary artery disease in young (age <45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

A prospective study of lipoprotein(a) and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

High lipoprotein(a) level promotes both coronary atherosclerosis and myocardial infarction: a path analysis using a large number of autopsy cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Lipoprotein(a) as a risk factor for preclinical atherosclerotic disease in a biracial cohort: the Atherosclerosis Risk in Communities (ARIC) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Delineation of prevalence and risk factors for early coronary artery disease by electron beam computed tomography in young adults with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

Plasma Lipoprotein(a) Indicates Risk for 4 Distinct Forms of Vascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-015-0072-2

10.1007/S11789-015-0072-2

21 January 2018

Identifiers

DOI

1 reference

16 May 2018

PubMed ID

25666917

1 reference

16 May 2018